Gordon EM - Search Results

1

Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety.

Robl JA, Duncan LA, Pluscec J, Karanewsky DS, Gordon EM, Ciosek CP Jr, Rich LC, Dehmel VC, Slusarchyk DA, Harrity TW, et al. Robl JA, et al. Among authors: gordon em. J Med Chem. 1991 Sep;34(9):2804-15. doi: 10.1021/jm00113a019. J Med Chem. 1991. PMID: 1895299

2

Isoprenyl phosphinylformates: new inhibitors of squalene synthetase.

Biller SA, Forster C, Gordon EM, Harrity T, Rich LC, Marretta J, Ciosek CP Jr. Biller SA, et al. Among authors: gordon em. J Med Chem. 1991 Jun;34(6):1912-4. doi: 10.1021/jm00110a024. J Med Chem. 1991. PMID: 2061928 No abstract available.

3

Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.

Karanewsky DS, Badia MC, Ciosek CP Jr, Robl JA, Sofia MJ, Simpkins LM, DeLange B, Harrity TW, Biller SA, Gordon EM. Karanewsky DS, et al. Among authors: gordon em. J Med Chem. 1990 Nov;33(11):2952-6. doi: 10.1021/jm00173a007. J Med Chem. 1990. PMID: 2231594 No abstract available.

4

Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase.

Biller SA, Forster C, Gordon EM, Harrity T, Scott WA, Ciosek CP Jr. Biller SA, et al. Among authors: gordon em. J Med Chem. 1988 Oct;31(10):1869-71. doi: 10.1021/jm00118a001. J Med Chem. 1988. PMID: 3172121 No abstract available.

5

Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.

Ciosek CP Jr, Magnin DR, Harrity TW, Logan JV, Dickson JK Jr, Gordon EM, Hamilton KA, Jolibois KG, Kunselman LK, Lawrence RM, et al. Ciosek CP Jr, et al. Among authors: gordon em. J Biol Chem. 1993 Nov 25;268(33):24832-7. J Biol Chem. 1993. PMID: 8227045 Free article.

6

Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme.

Cushman DW, Ondetti MA, Gordon EM, Natarajan S, Karanewsky DS, Krapcho J, Petrillo EW Jr. Cushman DW, et al. Among authors: gordon em. J Cardiovasc Pharmacol. 1987;10 Suppl 7:S17-30. doi: 10.1097/00005344-198706107-00004. J Cardiovasc Pharmacol. 1987. PMID: 2485059 Review.

7

Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.

Barrish JC, Gordon E, Alam M, Lin PF, Bisacchi GS, Chen P, Cheng PT, Fritz AW, Greytok JA, Hermsmeier MA. Barrish JC, et al. J Med Chem. 1994 Jun 10;37(12):1758-68. doi: 10.1021/jm00038a005. J Med Chem. 1994. PMID: 8021916

8

Ketomethylureas. A new class of angiotensin converting enzyme inhibitors.

Natarajan S, Gordon EM, Sabo EF, Godfrey JD, Weller HN, Pluscec J, Rom MB, Engebrecht J, Cushman DW, Deforrest JM, et al. Natarajan S, et al. Among authors: gordon em. J Enzyme Inhib. 1988;2(2):91-7. doi: 10.3109/14756368809040715. J Enzyme Inhib. 1988. PMID: 3236070

9

Design of novel inhibitors of aminopeptidases. Synthesis of peptide-derived diamino thiols and sulfur replacement analogues of bestatin.

Gordon EM, Godfrey JD, Delaney NG, Asaad MM, Von Langen D, Cushman DW. Gordon EM, et al. J Med Chem. 1988 Nov;31(11):2199-211. doi: 10.1021/jm00119a023. J Med Chem. 1988. PMID: 3184127

10

Farnesyl diphosphate-based inhibitors of Ras farnesyl protein transferase.

Patel DV, Schmidt RJ, Biller SA, Gordon EM, Robinson SS, Manne V. Patel DV, et al. Among authors: gordon em. J Med Chem. 1995 Jul 21;38(15):2906-21. doi: 10.1021/jm00015a013. J Med Chem. 1995. PMID: 7636851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page